What is IntimaLase®?
IntimaLase® is a patent-pending, innovative and unique non-invasive Er:YAG laser therapy. It is based on incisionless, non-ablative photothermal tightening of the vaginal canal. Preliminary clinical studies show that it is an efficient, easy-to-use, quick and safe procedure.
The indication for IntimaLase® is vaginal relaxation syndrome, which is the loss of the optimum structural form of the vagina. This process is generally associated with overstretching of the vaginal canal during childbirth as well as with natural aging.
How does IntimaLase® work?
The IntimaLase® treatment is based on laser-induced thermal effects in the vaginal tissue, stimulating collagen remodeling and the synthesis of new collagen fibers. The final result of collagen neogenesis and remodeling is tightening of the vaginal canal.
The laser used in IntimaLase® clinical trials is a 2940 nm Er:YAG with built-in proprietary technology solutions that enable delivery of specially composed laser energy packages to the vaginal mucosa tissue and to collagen-rich endopelvic fascia.
Unique advantages of IntimaLase® for your patients
For most patients included in the study, a single session was sufficient for significant tightening of the vaginal canal. If needed, the treatment was repeated after one month. No special pre-op preparation or post-op precautions were necessary. Patients could immediately return to their normal everyday activities. After one single treatment clinical results show a tightened vaginal canal, greater sexual satisfaction and significant improvement in a patient’s quality of life.
Promising clinical results
The latest scientific results presented by LAHA specialists Dr. Riviera and Dr. Fistonić clearly show noticeable improvements in vaginal tightness and sexual gratification. Assessments of the efficacy of IntimaLase® treatments are based on subjective patients’ evaluations through standardized questionnaires as well as objective measurements of vaginal canal tissue shrinkage.
Vaginal tightening was achieved in all patients, ranging from 3% to 28%, resulting in an average shrinkage of 17%. Measurements of sexual gratification with the McCoy Female Sexuality Questionnaire (MFSQ) showed an average improvement of 8.5 points on a 36 point scale.
Clinical results prove that the fast and easy-to-perform IntimaLase® treatment is an effective, non-invasive, incisionless procedure with no undesired side effects or contraindications.